As of Dec 02
| -0.03 / -1.86%|
The 2 analysts offering 12-month price forecasts for Idera Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate represents a +216.46% increase from the last price of 1.58.
The current consensus among 4 polled investment analysts is to Buy stock in Idera Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.